Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amicus Therapeutics (FOLD) Interest Coverage Ratio (2016 - 2025)

Amicus Therapeutics (FOLD) has disclosed Interest Coverage Ratio for 16 consecutive years, with 1.4 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Coverage Ratio rose 4.47% year-over-year to 1.4, compared with a TTM value of 0.71 through Dec 2025, up 41.63%, and an annual FY2025 reading of 0.71, up 41.63% over the prior year.
  • Interest Coverage Ratio was 1.4 for Q4 2025 at Amicus Therapeutics, down from 2.93 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 2.93 in Q3 2025 and bottomed at 9.25 in Q1 2022.
  • Average Interest Coverage Ratio over 5 years is 2.54, with a median of 1.87 recorded in 2024.
  • The sharpest move saw Interest Coverage Ratio surged 564.02% in 2024, then tumbled 168.48% in 2025.
  • Year by year, Interest Coverage Ratio stood at 8.84 in 2021, then surged by 56.83% to 3.82 in 2022, then surged by 92.46% to 0.29 in 2023, then soared by 564.02% to 1.34 in 2024, then rose by 4.47% to 1.4 in 2025.
  • Business Quant data shows Interest Coverage Ratio for FOLD at 1.4 in Q4 2025, 2.93 in Q3 2025, and 0.82 in Q2 2025.